SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma

NCT07234721 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Relapsed and Refractory Multiple Myeloma (RRMM)

Interventions

DRUG: SL4903 Autologous T-Cell Injection
DRUG: SL4903 Autologous T-Cell Injection
DRUG: SL4903 Autologous T-Cell Injection

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

[object Object]